SCHEMBL8178780

SCHEMBL8178780

C=C1CC[C@H](O[Si](C)(C)C(C)(C)C)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/C(O)C3(OC(=O)N(C)C)CC3)CC[C@@H]12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.50
▸ ADRA1A P35348 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ ALOX15 P16050 2/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ AR P10275 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ USP2 O75604 1/20 0.50
▸ ABCB11 O95342 1/20 0.50
▸ ESR1 P03372 1/20 0.50
▸ HSPD1 P10809 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ HSPE1 P61604 1/20 0.50
▸ TST Q16762 1/20 0.50
▸ VDR P11473 6/20 0.46
▸ MAPT P10636 2/20 0.43
▸ SREBF1 P36956 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8180236 0.90 VDR (0.49) LMNAADRA1AALDH1A1ALOX15CYP3A4
SCHEMBL8189784 0.90 VDR (0.49) LMNAADRA1AALDH1A1ALOX15CYP3A4
SCHEMBL7718670 0.89 LMNA (0.51) LMNAADRA1AALDH1A1ALOX15CYP3A4
SCHEMBL8193552 0.88 ALDH1A1 (0.48) LMNAADRA1AALDH1A1ALOX15CYP3A4
SCHEMBL7714416 0.85 ALDH1A1 (0.51) LMNAADRA1AALDH1A1ALOX15CYP3A4
SCHEMBL5433038 0.84 VDR (0.60) LMNAADRA1AALDH1A1ALOX15CYP3A4
SCHEMBL6045249 0.84 VDR (0.60) LMNAADRA1AALDH1A1ALOX15CYP3A4
SCHEMBL5438456 0.84 VDR (0.60) LMNAADRA1AALDH1A1ALOX15CYP3A4
SCHEMBL8529627 0.84 VDR (0.52) LMNAADRA1AALDH1A1ALOX15CYP3A4
SCHEMBL9265818 0.84 VDR (0.52) LMNAADRA1AALDH1A1ALOX15CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832063-B1 VITAMIN D DERIVATIVES WITH C-25 SUBSTITUENTS, PROCESS FOR THEIR PREPARATION, INTERMEDIATE PRODUCTS AND THEIR USE IN PREPARING MEDICAMENTS SCHERING AG (DE) 2000-02-23 — — EP disclosed
Send feedback